Nitisinone Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 2 mg and 5 mg
Reference Brands: Orfadin®
Category:
Orphan Drugs
Nitisinone inhibits the enzyme 4-hydroxyphenylpyruvate dioxygenase, reducing the production of toxic metabolites in hereditary tyrosinemia type 1 (HT-1). Benefits include preventing liver and kidney damage, decreasing hypersensitivity reactions, and improving survival rates in HT-1 patients by controlling disease progression.
Nitisinone tablets is available in Tablets
and strengths such as 2 mg and 5 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Nitisinone tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Nitisinone tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Nitisinone inhibits the enzyme 4-hydroxyphenylpyruvate dioxygenase, reducing the production of toxic metabolites in hereditary tyrosinemia type 1 (HT-1). Benefits include preventing liver and kidney damage, decreasing hypersensitivity reactions, and improving survival rates in HT-1 patients by controlling disease progression.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing